- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01393886
LGCP (Laparoscopic Greater Curvature Plication) (LGCP)
February 1, 2013 updated by: Heekoung A Youn, NYU Langone Health
A Prospective, Open-label Study to Evaluate the Safety and Efficacy of Laparoscopic Greater Curvature Plication (LGCP) in the Treatment of Obese Patients
The aim of this study is to find out the safety and efficacy of Laparoscopic Greater Curvature Plication (LGCP) procedure.
This study procedure is an alternative restrictive weight loss surgery that has the potential to reduce the complications associated with gastric banding and sleeve gastrectomy by creating a small sized stomach without the use of an implant and without cutting stomach.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
STUDY OBJECTIVES: To demonstrate the safety and efficacy of Laparoscopic Greater Curvature Plication (LGCP)
DESIGN: Prospective, open-label, and single center
Study Type
Interventional
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject is at least 18 years of age at the time of enrollment into the study;
- Have a BMI of at least 30;
- Subject is willing to give consent and comply with protocol evaluation and treatment schedules;
- Subject agrees to refrain from any type of weight-loss drug (prescription or OCT) or elective procedure that affect body weight for the duration of the trial; and
- HbA1C<11%
Exclusion Criteria:
- History of previous malabsorptive bariatric procedures;
- Women of childbearing potential who are pregnant or lactating at the time of screening or at the time of surgery;
- Any condition which precludes compliance with the study;
- History or presence of pre-existing autoimmune connective tissue disease; and
- Use of prescription or over the counter weight reduction medications or supplements within 30 days of the screening visit or the duration of study participation.
This study is a local study (NY, within 50 miles). This study is not a sponsored trial. Therefore, the procedure is not free.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Laparoscopic Greater Curvature Plication
Only one treatment arm
|
This procedure creates a small sized stomach by folding the stomach twice into itself vertically.
The functional capacity of the stomach is decreased by 80% of its normal(At least two rows of five continuous stitches are placed laparoscopically about the greater curvature of the stomach starting at or near the angle of His and ending in the antrum).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Loss
Time Frame: 12 months
|
The primary effectiveness endpoint is % of subjects who attain clinically successful weight loss at one year post LGCP.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Morbidity rates
Time Frame: 12 months
|
Morbidity rates
|
12 months
|
|
Mortality rates
Time Frame: 12 month
|
Mortality rates
|
12 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Fielding George, M.D., NYU SOM
- Principal Investigator: Christine Fielding, M.D., NYU SOM
- Principal Investigator: Marina Kurian, M.D., NYU SOM
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
June 9, 2011
First Submitted That Met QC Criteria
July 12, 2011
First Posted (Estimate)
July 13, 2011
Study Record Updates
Last Update Posted (Estimate)
February 5, 2013
Last Update Submitted That Met QC Criteria
February 1, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R11-00797
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Laparoscopic Greater Curvature Plication (LGCP)
-
Ponce, Jaime, M.D.CompletedMorbid ObesityUnited States
-
Singh, Kuldeep, M.D., P.A.UnknownMorbid ObesityUnited States
-
Singh, Kuldeep, M.D., P.A.Unknown
-
Northwell HealthCompletedMorbid ObesityUnited States
-
Virginia Commonwealth UniversityChildren's Hospital of RichmondCompletedObesityUnited States
-
Baystate Medical CenterTerminatedMorbid ObesityUnited States
-
Health Science University Zeynep Kamil Women and...RecruitingPelvic Organ Prolapse | Prolapse Bladder | Prolapse UterusTurkey
-
Institute for Clinical and Experimental MedicineNot yet recruiting
-
University Hospital OstravaUniversity of Ostrava; Vitkovice Hospital, Ostrava, Czech RepublicCompleted
-
Cairo UniversityCompleted